Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Theseus Pharmaceuticals I...

    NASDAQ: THRX · Real-Time Price · USD
    4.07
    0.01 (0.25%)
    At close: Feb 13, 2024, 9:59 PM

    Theseus Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a
    Cost of Revenue
    		 438K 2K
    Gross Profit
    		 -438K -2K
    Operating Income
    		 -54.09M -27.34M
    Interest Income
    		 n/a 28.00
    Pretax Income
    		 -50.61M -27.31M
    Net Income
    		 -47.08M -27.31M
    Selling & General & Admin
    		 18.39M 9.01M
    Research & Development
    		 35.7M 18.33M
    Other Expenses
    		 n/a 28K
    Operating Expenses
    		 54.09M 27.34M
    Interest Expense
    		 n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 54.09M 27.34M
    Income Tax Expense
    		 -3.53M n/a
    Shares Outstanding (Basic)
    		 38.49M 35.87M
    Shares Outstanding (Diluted)
    		 38.49M 35.87M
    EPS (Basic)
    		 -1.22 -0.76
    EPS (Diluted)
    		 -1.22 -0.76
    EBITDA
    		 -54.09M -27.33M
    EBIT
    		 -54.14M -27.34M
    Depreciation & Amortization
    		 50K 2K

    Add to Watchlist